ARTICLE | Finance
Highlights of weekly biotech stock moves
Regulatory, clinical and other milestones
July 14, 2014 7:00 AM UTC
Regulatory milestones
AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) was down $0.96 to $10.54 last week after partner Gruenenthal Group submitted an MAA to EMA for Zalviso to treat moderate to severe acute pain...